Neurocrine Biosciences, Inc. (NBIX)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
| Application | Product Name | Active Ingredient | Form | Strength | Status | ||
|---|---|---|---|---|---|---|---|
| NDA218390 - NEUROCRINE | |||||||
| INGREZZA SPRINKLE | VALBENAZINE TOSYLATE | CAPSULE;ORAL | EQ 40MG BASE | Prescription | |||
| INGREZZA SPRINKLE | VALBENAZINE TOSYLATE | CAPSULE;ORAL | EQ 60MG BASE | Prescription | |||
| INGREZZA SPRINKLE | VALBENAZINE TOSYLATE | CAPSULE;ORAL | EQ 80MG BASE | Prescription | |||
| NDA209241 - NEUROCRINE | |||||||
| INGREZZA | VALBENAZINE TOSYLATE | CAPSULE;ORAL | EQ 80MG BASE | Prescription | |||
| INGREZZA | VALBENAZINE TOSYLATE | CAPSULE;ORAL | EQ 60MG BASE | Prescription | |||
| INGREZZA | VALBENAZINE TOSYLATE | CAPSULE;ORAL | EQ 40MG BASE | Prescription | |||